Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Glucaric acid

Home DrugsGlucaric acid

Experimental

Small Molecule

Glucaric acid

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Technical identifiers

Chemical Formula: C₆H₁₀O₈
CAS Number: 87-73-0
UNII ID: QLZ991V4A2

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Application of glucaric acid 1, 4-lactone and lenvatinib composition in preparation of STAT3 phosphorylation inhibitor
Applicant: UNIV LISHUIPriority: 2025
CN
Application of D-glucaric acid-1, 4-lactone in preparation of medicine for relieving intestinal injury caused by sorafenib
Applicant: UNIV SUN YAT SENPriority: 2025
CN
Production of adipic acid and derivatives from carbohydrate-containing materials
Applicant: RENNOVIA INCPriority: 2009
CN
Production of adipic acid and derivatives from carbohydrate-containing materials
Applicant: BOUSSIE THOMAS RPriority: 2010
EP
US
6 publications
Novel method for synthesizing mixed glucose derivative
Applicant: UNIV NANJING FORESTRYPriority: 2009
CN
Pharmaceutical composition for treating drug-induced liver injury and application thereof
Applicant: UNIV LISHUIPriority: 2025
CN
Therapeutic agent for the use in reducing alcohol intoxication and reducing or eliminating the negative side effects associated with alcohol ingestion
Applicant: ANDREWS ALANPriority: 2003
US
2 publications
Compositions and methods for producing 2, 5-furandicarboxylic acid
Applicant: SOLUGEN INCPriority: 2020
CN